Clinical Course of COVID-19 in Children With Adrenal Insufficiency: Results From National Data - Summary - MDSpire

Clinical Course of COVID-19 in Children With Adrenal Insufficiency: Results From National Data

  • By

  • Donatella Capalbo

  • Cristina Moracas

  • Laura Guazzarotti

  • Federico Baronio

  • Marianna Rita Stancampiano

  • Rita Ortolano

  • Mariella Valenzise

  • Carla Bizzarri

  • Giuseppa Patti

  • Silvia Longhi

  • Claudia Giavoli

  • Chiara Guzzetti

  • Silvia Zoletto

  • Crescenza Lattanzio

  • Paolo Cavarzere

  • Maria Elisabeth Street

  • Maria Felicia Faienza

  • Anna Grandone

  • Marco Cappa

  • Malgorzata Gabriela Wasniewska

  • Gianni Russo

  • Mohamad Maghnie

  • Mariacarolina Salerno

  • On behalf of the Study Group for Adrenal Diseases of the Italian Society for Pediatric Endocrinology and Diabetes

  • February 7, 2025

  • 0 min

Share

Objective:

To evaluate whether children with adrenal insufficiency (AI) are more susceptible to SARS-CoV-2 infection or at risk of severe COVID-19, focusing on specific outcomes such as infection rates and severity of illness.

Key Findings:
  • Prevalence of COVID-19 in the AI cohort was 12.9%, not increased compared to the general pediatric population.
  • Severity of COVID-19 was similar in AI subjects and controls, with specific percentages for asymptomatic, mild, and severe cases.
  • Only 5 patients (3.4%) experienced an adrenal crisis during severe COVID-19.
  • Hospitalization rates were the same in patients and controls (9.5%).
  • All subjects completely recovered with no COVID-related deaths.
Interpretation:

The study suggests that children with adrenal insufficiency do not have increased susceptibility to SARS-CoV-2 infection or higher risk for severe COVID-19.

Limitations:
  • Retrospective design may introduce bias, affecting the reliability of the findings.
  • Exclusion of patients with tertiary AI related to steroid use limits generalizability to the broader AI population.
  • Limited data on long-term outcomes post-COVID-19 restricts understanding of potential lasting effects.
Conclusion:

Findings indicate that AI in children does not correlate with increased risk of severe COVID-19, providing reassurance for this patient population and suggesting areas for future research.

Original Source(s)

Related Content